Michael Weber

Weber, Michael J.

Primary Appointment

Professor Emeritus, Microbiology, Immunology, and Cancer Biology


  • BS, Biology, Haverford College, Haverford, PA
  • PhD, Biology, University of California, San Diego, CA
  • Postdoc, Virology, University of California, Berkeley, CA

Contact Information

PO Box 800734
1300 Jefferson Park Avenue
Charlottesville, VA 22908-0734
Telephone: 434-924-5022
Fax: 434-982-0689
Email: mjw@virginia.edu

Research Interests

Targeting Cell Signaling for Cancer Therapy.

Research Description

Cells continually make decisions about their fate: growth, death or differentiation. These decisions frequently are determined by signal transduction cascades of small GTP-binding proteins and protein kinases, which are activated in response to extracellular signals. Our laboratory utilizes tools of cell biology, protein chemistry and molecular biology to understand how signal transduction controls cell growth and apoptosis, how these controls are altered in cancer, and how this information can be used to improve cancer treatment.

MAP kinases: regulation and function.

MAP Kinase cascades are among the most thoroughly studied of signal transduction systems, and have been shown to participate in a diverse array of cellular programs including cell differentiation, cell movement, cell division and cell death. They typically are organized in a three-kinase architecture consisting of a MAP Kinase (MAPK), a MAP Kinase activator (MEK) and a MEK activator (MEKK). Transmission of signals is achieved by sequential phosphorylation and activation of the components specific to a respective cascade. In mammalian systems five distinguishable MAP Kinase modules have been identified so far. These include the canonical ERK1/2 cascade that preferentially regulates cell growth and differentiation. Increased understanding of the ways these enzymes are regulated, targeted intracellularly and linked with other signaling pathways will enhance our insight into the regulatory networks that control cell behavior and provide clues as to how to exploit these as targets for therapy.

Signal transduction in human cancer.
Cancers undergo progressive changes that increase their malignant potential and thereby render them less susceptible to treatment. Analysis of the cellular signaling mechanisms that link the outside of the cancer cell to receptors and intracellular signal transduction cascades will provide insight into prevention, detection, and treatment strategies for cancer. Much of our recent efforts have been on elucidating the ways that redundant and compensatory signaling pathways neutralize the effects of targeted therapies and lead to drug resistance. We currently are using cell and xenograft cancer systems in melanoma, as well as patient samples in B-Cell malignancies each of which provides unique opportunities to match knowledge about signaling with potential therapeutic interventions.

Selected Publications